Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.
- DOI
- 10.3390/ph19050792
- Published
- 2026 May 19
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph19050792,
title = {Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.},
author = {Setiawan AW and Choi J and Park S and Choi M and Tjandrawinata RR and Hadinata E and Park MN and Ikrar T and Nurkolis F and Kim B},
year = {2026},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph19050792},
url = {https://doi.org/10.3390/ph19050792}
}RIS
TY - JOUR TI - Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges. AU - Setiawan AW AU - Choi J AU - Park S AU - Choi M AU - Tjandrawinata RR AU - Hadinata E AU - Park MN AU - Ikrar T AU - Nurkolis F AU - Kim B PY - 2026 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph19050792 UR - https://doi.org/10.3390/ph19050792 ER -
APA
AW, S., J, C., S, P., M, C., RR, T., E, H., MN, P., T, I., F, N., & B, K. (2026). Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19050792
Source records
- pubmed · retrieved 2026-09-26T14:03:54.814Z